The DOI matches its Crossref record; 160 of the 165 references it cites were found in a registry or an index.
Interleukin-18, more than a Th1 cytokine
Abstract
Together with IL-12 or IL-15, interleukin-18 (IL-18) plays a major role in the production of interferon-γ from T-cells and natural killer cells; thus, IL-18 is considered to have a major role in the Th1 response. However, without IL-12, IL-18 is proinflammatory in an IFNγ independent manner. IL-18 is a member of the IL-1 family of cytokines and similar to IL-1β, the cytokine is synthesized as an inactive precursor requiring processing by caspase-1 into an active cytokine. IL-18 is also present as an integral membrane protein but requires caspase-1 for full activity in order to induce IFNγ. Uniquely, unlike IL-1β, the IL-18 precursor is constitutively present in nearly all cells in healthy humans and animals. The activity of IL-18 is balanced by the presence of a high-affinity, naturally occurring IL-18 binding protein (IL-18BP). In humans, increased disease severity can be associated with an imbalance of IL-18 to IL-18BP such that the levels of free IL-18 are elevated in the circulation. Increasing number of studies have expanded the role of IL-18 in mediating inflammation in animal models of disease using the IL-18BP, IL-18 deficient mice, neutralization of IL-18 or deficiency in the IL-18 receptor alpha chain. A role for IL-18 has been implicated in several autoimmune diseases, myocardial function, emphysema, metabolic syndromes, psoriasis, inflammatory bowel disease, macrophage activation syndrome, sepsis and acute kidney injury, although paradoxically, in some models of disease, IL-18 is protective. The IL-18BP has been used safely in humans and clinical trials of IL-18BP as well as neutralizing anti-IL-18 antibodies are being tested in various diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The ratio of free interleukin-18 to bound interleukin-18–IL18BP complexes in serum is an important indicator of the severity of the macrophage activation syndrome.44,47”
From Cytokine storm (2020) · cites this paper as [47]
Citations
Cites
Cloning of a new cytokine that induces IFN-γ production by T cells
Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., et al. (1995) · Nature · doi:10.1038/378088a0 · Cited by 2,602
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024
Sutton, C. E., Lalor, S. J., Sweeney, C. M., Brereton, C. F., Lavelle, E. C., & Mills, K. H. G. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.001 · Cited by 1,553
Interleukin-18 Regulates Both Th1 and Th2 Responses
Nakanishi, K., Yoshimoto, T., Tsutsui, H., & Okamura, H. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.423 · Cited by 1,319
Sutton, C. E., Brereton, C. F., Keogh, B., Mills, K. H. G., & Lavelle, E. C. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060285 · Cited by 1,038
An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist
Aksentijevich, I. A., Masters, S. L., Ferguson, P. J., Dancey, P., Frenkel, J., van Royen‐Kerkhof, A., Laxer, R. M., Tedgård, U., Cowen, E. W., Pham, T., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807865 · Cited by 981
Weber, A., Wasiliew, P., & Kracht, M. (2010) · Science Signaling · doi:10.1126/scisignal.3105cm1 · Cited by 962
Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome
Bauer, C. A., Duewell, P., Mayer, C., Lehr, H. A., Fitzgerald, K. A., Dauer, M., Tschopp, J., Endres, S., Latz, E., & Schnurr, M. M. (2010) · Gut · doi:10.1136/gut.2009.197822 · Cited by 928
Chen, C.-J., Kono, H., Golenbock, D., Reed, G., Akira, S., & Rock, K. L. (2007) · Nature Medicine · doi:10.1038/nm1603 · Cited by 876
Anti–Interleukin-12 Antibody for Active Crohn's Disease
Mannon, P., Fuss, I. J., Mayer, L., Elson, C. O., Sandborn, W. J., Present, D. H., Dolin, B. J., Goodman, N., Groden, C. A., Hornung, R. L., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033402 · Cited by 844
Flagged first, then by citations
5 of the 165 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Fajgenbaum, D. C., & June, C. H. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2026131 · Cited by 3,196
Canna, S., de Jesus, A. A., Gouni, S., Brooks, S. R., Marrero, B., Liu, Y., DiMattia, M. A., Zaal, K. J. M., Sanchez, G. A. M., Kim, H., et al. (2014) · Nature Genetics · doi:10.1038/ng.3089 · Cited by 747
Interleukin‐18: Biological properties and role in disease pathogenesis
Kaplanski, G. (2017) · Immunological Reviews · doi:10.1111/imr.12616 · Cited by 621
Self-citationGerfaud‐Valentin, M., Jamilloux, Y., Iwaz, J., & Sève, P. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.058 · Cited by 526
Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme
Afonina, I. S., Müller, C., Martin, S. J., & Beyaert, R. (2015) · Immunity · doi:10.1016/j.immuni.2015.06.003 · Cited by 483
Targeting cytokines to treat asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2018) · Nature reviews. Immunology · doi:10.1038/s41577-018-0006-6 · Cited by 432
Biomarkers in acute kidney injury – pathophysiological basis and clinical performance
Schrezenmeier, E. V., Barasch, J. M., Budde, K., Westhoff, T. H., & Schmidt-Ott, K. M. (2016) · Acta Physiologica · doi:10.1111/apha.12764 · Cited by 431
Weiss, E. S., Girard-Guyonvarc’h, C., Holzinger, D., de Jesus, A. A., Tariq, Z., Picarsic, J. L., Schiffrin, E. J., Foell, D., Grom, A. A., Ammann, S., et al. (2018) · Blood · doi:10.1182/blood-2017-12-820852 · Cited by 406
The family of the interleukin‐1 receptors
Boraschi, D., Italiani, P., Weil, S., & Martin, M. U. (2017) · Immunological Reviews · doi:10.1111/imr.12606 · Cited by 399
Ihim, S. A., Abubakar, S. D., Zian, Z., Sasaki, T., Saffarioun, M., Maleknia, S., & Azizi, G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.919973 · Cited by 417
Dupaul-Chicoine, J., Arabzadeh, A., Dagenais, M., Douglas, T., Champagne, C., Morizot, A., Rodrigue-Gervais, I. G., Breton, V., Colpitts, S. L., Beauchemin, N., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.013 · Cited by 342
Molecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity
Hou, J., Hsu, J.-M., & Hung, M. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.09.003 · Cited by 309
The IL-1 cytokine family and its role in inflammation and fibrosis in the lung
Borthwick, L. A. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0559-z · Cited by 294
Bracaglia, C., de Graaf, K., Marafon, D. P., Guilhot, F., Ferlin, W. G., Prencipe, G., Caiello, I., Davì, S., Schulert, G. S., Ravelli, A., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-209020 · Cited by 290
Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption
KASHANI, K. B., Cheungpasitporn, W., & Ronco, C. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0973 · Cited by 298
Ballak, D. B., Stienstra, R., Tack, C. J., Dinarello, C. A., & van Diepen, J. A. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.005 · Cited by 265
Self-citationOf Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease
Anders, H. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016020177 · Cited by 258
P2X7 receptor and the NLRP3 inflammasome: Partners in crime
Pelegrín, P. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114385 · Cited by 253
The NLRP3 inflammasome in kidney disease and autoimmunity
Hutton, H., Ooi, J. D., Holdsworth, S. R., & Kitching, A. R. (2016) · Nephrology · doi:10.1111/nep.12785 · Cited by 237
The Mechanism behind Influenza Virus Cytokine Storm
Gu, Y., Zuo, X., Zhang, S., Ouyang, Z., Jiang, S., Wang, F., & Wang, G. (2021) · Viruses · doi:10.3390/v13071362 · Cited by 241
Martínez-García, J. J., Martínez-Banaclocha, H., Angosto-Bazarra, D., de Torre-Minguela, C., Baroja-Mazo, A., Alarcón-Vila, C., Martínez-Alarcón, L., Amores-Iniesta, J., Martín-Sánchez, F., Ercole, G. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10626-x · Cited by 233
Interleukin-1 as Innate Mediator of T Cell Immunity
Eeckhout, B. V. D., Tavernier, J. H., & Gerlo, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.621931 · Cited by 227
Amores, J., Barberà-Cremades, M., Martínez, C. M., Pons, J. A., Revilla‐Nuin, B., Martínez-Alarcón, L., Virgilio, F. D., Parrilla, P., Baroja‐Mazo, A., & Pelegrín, P. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.079 · Cited by 187
Guo, Q., Wu, Y., Hou, Y., Liu, Y., Liu, T., Zhang, H., Fan, C., Guan, H., Li, Y., Shan, Z., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01197 · Cited by 180
Yazdi, A. S., & Ghoreschi, K. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-0921-5_2 · Cited by 174
Macrophage Activation Syndrome: different mechanisms leading to a one clinical syndrome
Bracaglia, C., Prencipe, G., & Benedetti, F. D. (2017) · Pediatric Rheumatology · doi:10.1186/s12969-016-0130-4 · Cited by 160
Silberstein, L., Goncalves, K. A., Kharchenko, P. V., Turcotte, R., Kfoury, Y. S., Mercier, F., Baryawno, N., Sévère, N., Bachand, J., Spencer, J. A., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.07.004 · Cited by 159
Interleukin 18 (IL-18) as a target for immune intervention.
Wawrocki, S., Druszczyńska, M., Kowalewicz‐Kulbat, M., & Rudnicka, W. (2016) · Acta Biochimica Polonica · doi:10.18388/abp.2015_1153 · Cited by 147
Pateras, I. S., Havaki, S., Nikitopoulou, X., Vougas, K. N., Townsend, P. A., Panayiotidis, M. I., Georgakilas, A. G., & Gorgoulis, V. G. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.011 · Cited by 147
The IL-1 family cytokines and receptors in autoimmune diseases
Migliorini, P., Italiani, P., Pratesi, F., Puxeddu, I., & Boraschi, D. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102617 · Cited by 137
Matias, M. L., Romão‐Veiga, M., Weel, I. C., Ribeiro, V. R., Nunes, P. R., Borges, V. T. M., Araújo, J. P., Peraçoli, J. C., Oliveira, L. G., & Peraçoli, M. T. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129095 · Cited by 131
Lee, S., Suh, G. Y., Ryter, S. W., & Choi, A. M. K. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0231tr · Cited by 130
IL‐18 and infections: Is there a role for targeted therapies?
Vecchié, A., Bonaventura, A., Toldo, S. A., Dagna, L., Dinarello, C. A., & Abbate, A. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30008 · Cited by 127
Self-citationLee, H., Fessler, M. B., Qu, P., Heymann, J. A. W., & Kopp, J. B. (2020) · BMC Nephrology · doi:10.1186/s12882-020-01921-7 · Cited by 124
Pyroptosis-Induced Inflammation and Tissue Damage
Wei, Y., Yang, L., Pandeya, A., Cui, J., Zhang, Y., & Li, Z. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167301 · Cited by 130
A Role for the Inflammasome in Spontaneous Preterm Labor With Acute Histologic Chorioamnionitis
Gomez‐Lopez, N., Romero, R. J., Xu, Y., Plazyo, O., Unkel, R., Leng, Y., Than, N. G., Chaiworapongsa, T., Panaitescu, B., Dong, Z., et al. (2017) · Reproductive Sciences · doi:10.1177/1933719116687656 · Cited by 108
A Role for the Inflammasome in Spontaneous Labor at Term
Romero, R. J., Xu, Y., Plazyo, O., Chaemsaithong, P., Chaiworapongsa, T., Unkel, R., Than, N. G., Chiang, P. J., Dong, Z., Xu, Z., et al. (2016) · American Journal of Reproductive Immunology · doi:10.1111/aji.12440 · Cited by 110
Extracellular ATP and other nucleotides—ubiquitous triggers of intercellular messenger release
Zimmermann, H. (2015) · Purinergic Signalling · doi:10.1007/s11302-015-9483-2 · Cited by 112
IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κB
Victor, A. R., Nalin, A. P., Dong, W., McClory, S., Wei, M., Mao, C., Kladney, R. D., Youssef, Y., Chan, W. K., Briercheck, E. L., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601554 · Cited by 100
Itani, S., Watanabe, T., Nadatani, Y., Sugimura, N., Shimada, S., Takeda, S., Otani, K., Hosomi, S., Nagami, Y., Tanaka, F., et al. (2016) · Scientific Reports · doi:10.1038/srep39075 · Cited by 97
IL-1 Inhibition and Vascular Function in CKD
Nowak, K. L., Chonchol, M., Ikizler, T. A., Farmer‐Bailey, H., Salas, N., Chaudhry, R., Wang, W., Smits, G., Tengesdal, I. W., Dinarello, C. A., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016040453 · Cited by 94
Self-citationDura, B., Servos, M. M., Barry, R. M., Ploegh, H. L., Dougan, S. K., & Joel Voldman, B. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515364113 · Cited by 97
Cytokines and Interferons: Types and Functions
Ferreira, V. L., Borba, H. H. L., Bonetti, A. D. F., Leonart, L. P., & Pontarolo, R. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.74550 · Cited by 94
Ge, Y., Huang, M., & Yao, Y.-M. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.12.004 · Cited by 86
Inflammasome: Cancer's friend or foe?
Terlizzi, M., Casolaro, V., Pinto, A., & Sorrentino, R. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.002 · Cited by 87
Tan, H. Y., Yong, Y. K., Shankar, E. M., Paukovics, G., Ellegård, R., Larsson, M., Kamarulzaman, A., French, M. A., & Crowe, S. M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502203 · Cited by 77
Convergent pathways of the hyperferritinemic syndromes
Schulert, G. S., & Canna, S. (2018) · International Immunology · doi:10.1093/intimm/dxy012 · Cited by 77
Roberto, A., Vito, C. D., Zaghi, E., Mazza, E. M. C., Capucetti, A., Calvi, M., Tentorio, P., Zanon, V., Sarina, B., Mariotti, J., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.186619 · Cited by 75
Shaler, C. R., Tun‐Abraham, M. E., Skaro, A. I., Khazaie, K., Corbett, A. J., Mele, T. S., Hernandez‐Alejandro, R., & Haeryfar, S. M. M. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-2050-7 · Cited by 74
Immunological effects of shift work in healthcare workers
Loef, B., Nanlohy, N. M., Jacobi, R. H. J., van de Ven, C., Mariman, R., van der Beek, A. J., Proper, K. I., & van Baarle, D. (2019) · Scientific Reports · doi:10.1038/s41598-019-54816-5 · Cited by 75
Macrophage activation syndrome in the course of monogenic autoinflammatory disorders
Rigante, D., Emmi, G., Fastiggi, M., Silvestri, E., & Cantarini, L. (2015) · Clinical Rheumatology · doi:10.1007/s10067-015-2923-0 · Cited by 73
Involvement of Inflammasome Components in Kidney Disease
Aranda‐Rivera, A. K., Srivastava, A., Cruz‐Gregorio, A., Pedraza‐Chaverrí, J., Mulay, S. R., & Scholze, A. (2022) · Antioxidants · doi:10.3390/antiox11020246 · Cited by 76
Nielsen, C. M., Wolf, A., Goodier, M. R., & Riley, E. M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00101 · Cited by 70
Almutairi, S. M., Ali, A. K., He, W. R., Yang, D.-S., Ghorbani, P., Wang, L., Fullerton, M. D., & Lee, S.-H. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005892 · Cited by 74
Zhang, L.-M., Zhang, J., Zhang, Y., Fei, C., Wang, L., Yi, Z., & Zhang, Z.-Q. (2019) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2019.108756 · Cited by 67
Pardeo, M., Bracaglia, C., & De Benedetti, F. (2017) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2018.02.002 · Cited by 60
Inflammasome as a promising therapeutic target for cancer
Lee, C., Do, H. T. T., Her, J., Kim, Y., Seo, D., & Rhee, I. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116593 · Cited by 66
New biomarkers in acute kidney injury
Rossiter, A., La, A. M., Koyner, J. L., & Forni, L. G. (2023) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2023.2242481 · Cited by 69
Han, J. H., Suh, C., Jung, J., Ahn, M., Han, M. H., Kwon, J. E., Yim, H., & Kim, H. (2017) · Scientific Reports · doi:10.1038/srep46652 · Cited by 65
Gut mycobiome: A promising target for colorectal cancer
Qin, X., Gu, Y., Liu, T., Wang, C., Zhong, W., Wang, B., & Cao, H. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188489 · Cited by 63
Song, Y., Pei, L., Chen, L., Geng, H., Yuan, M., Xu, W., Wu, J., Zhou, J., & Sun, J. (2020) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x20500044 · Cited by 63
Vigo, T., Procaccini, C., Ferrara, G. B., Baranzini, S. E., Oksenberg, J. R., Matarese, G., Diaspro, A., de Rosbo, N. K., & Uccelli, A. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.09.004 · Cited by 62
Tan, H. Y., Yong, Y. K., Andrade, B. B., Shankar, E. M., Ponnampalavanar, S. S. L., Omar, S. F. S., Narendran, G., Kamarulzaman, A., Swaminathan, S., Sereti, I., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000557 · Cited by 62
Malengier‐Devlies, B., Metzemaekers, M., Wouters, C. H., Proost, P., & Matthys, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.766620 · Cited by 64
Polymorphisms in TICAM2 and IL1B are associated with TB
Hall, N. B., Igo, R. P., Malone, L., Truitt, B. J., Schnell, A., Tao, L., Okware, B., Nsereko, M., Chervenak, K. A., Lancioni, C., et al. (2014) · Genes and Immunity · doi:10.1038/gene.2014.77 · Cited by 60
NLRP3 inflammasome in colitis and colitis-associated colorectal cancer
Perera, A. P., Sajnani, K., Dickinson, J. L., Eri, R. D., & Körner, H. (2018) · Mammalian Genome · doi:10.1007/s00335-018-9783-2 · Cited by 61
Role for IL-1 Family Cytokines in Fungal Infections
Griffiths, J. S., Camilli, G., Kotowicz, N. K., Ho, J., Richardson, J. P., & Naglik, J. R. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.633047 · Cited by 58
Wu, L., Zhang, Y., Yang, Y., Lin, B., Zhu, M., Xu, J., Chen, Y., Wu, W., Chen, B., Chen, X., et al. (2023) · Advanced Science · doi:10.1002/advs.202303908 · Cited by 56
Hero turned villain: NLRP3 inflammasome-induced inflammation during influenza A virus infection
Ong, J. D. H., Mansell, A. S., & Tate, M. D. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.4mr0616-288r · Cited by 60
The NLRP 3 inflammasome contributes to host protection during Sporothrix schenckii infection
Gonçalves, A. C., Ferreira, L. S., Manente, F. A., de Faria, C. M. Q. G., Polesi, M. C., de Andrade, C. R., Zamboni, D. S., & Carlos, I. Z. (2017) · Immunology · doi:10.1111/imm.12719 · Cited by 55
Jordan, M. B. (2023) · Immunological Reviews · doi:10.1111/imr.13298 · Cited by 53
Inhibition of IL-18 reduces renal fibrosis after ischemia-reperfusion
Liang, H., Xu, F., Zhang, T., Huang, J., Guan, Q., Wang, H., & Huang, Q. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.031 · Cited by 53
Immunoregulatory mechanism of acute kidney injury in sepsis: A Narrative Review
Sun, S., Chen, R., Dou, X., Dai, M., Long, J., Wu, Y., & Lin, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114202 · Cited by 53
IL-18 and IL-18BP: A Unique Dyad in Health and Disease
Novick, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413505 · Cited by 56
Self-citationOld Dogs, New Tricks: Monogenic Autoinflammatory Disease Unleashed
Stoffels, M., & Kastner, D. L. (2016) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090413-025334 · Cited by 53
Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives
Ambler, W. G., Nanda, K., Onel, K. B., & Shenoi, S. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2095431 · Cited by 51
Balance between Interleukin-18 and Interleukin-18 binding protein in auto-inflammatory diseases
Harel, M., Fauteux‐Daniel, S., Girard-Guyonvarc'h, C., & Gabay, C. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155781 · Cited by 50
Detection of Serum Interleukin‐6/10/18 Levels in Sepsis and Its Clinical Significance
Feng, M., Sun, T., Zhao, Y., & Zhang, H. (2016) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21977 · Cited by 50
Martinović, K. M., Babović, N. L., Džodić, R. R., Jurišić, V., Matković, S., & Konjević, G. M. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0479-z · Cited by 49
Autoinflammatory Diseases and Cytokine Storms—Imbalances of Innate and Adaptative Immunity
Marcuzzi, A., Melloni, E., Zauli, G., Romani, A., Secchiero, P., Maximova, N., & Rimondi, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011241 · Cited by 52
Richter, K., Sagawe, S., Hecker, A., Küllmar, M., Askevold, I. H., Damm, J., Heldmann, S., Pöhlmann, M., Ruhrmann, S., Sander, M., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01604 · Cited by 48
Innate inflammation drives NK cell activation to impair Treg activity
Dean, J. W., Peters, L. D., Fuhrman, C. A., Seay, H. R., Posgai, A. L., Stimpson, S. E., Brusko, M., Perry, D. J., Yeh, W.-I., Newby, B. N., et al. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102417 · Cited by 50
Olivera, I., Bolaños, E., González-Gomariz, J., Hervás‐Stubbs, S., Mariño, K. V., Luri‐Rey, C., Etxeberría, I., Cirella, A., Egea, J., Glez‐Vaz, J., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.100978 · Cited by 46
Jin, H., Ko, G. H., & Kim, H. J. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4552 · Cited by 48
Zhang, L., Zhang, Y., Chang, F., Zhang, J., Wang, L., Yi, Z.-W., & Gao, G. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.11.129 · Cited by 47
Zhang, W.-G., Guo, S., Li, B., Liu, L., Ge, R., Cao, T., Wang, H., Gao, T.-W., Wang, G., & Li, C.-Y. (2016) · Journal of Pathology · doi:10.1002/path.4848 · Cited by 43
Allam, O., Samarani, S., Mehraj, V., Jenabian, M.-A., Tremblay, C. L., Routy, J., Amre, D. K., & Ahmad, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194185 · Cited by 45
Chognard, G., Bellemare, L., Pelletier, A., Domínguez-Punaro, M. D. L. C., Beauchamp, C., Guyon, M.-J., Charron, G., Morin, N., Sivanesan, D., Kuchroo, V. K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089092 · Cited by 43
Lin, W., Zhao, Z., Ni, Z., Zhao, Y., Du, W., & Chen, S. (2017) · Cell Proliferation · doi:10.1111/cpr.12392 · Cited by 43
IL-37 As a Potential Biotherapeutics of Inflammatory Diseases
Bai, J., Li, Y., Li, M., Tan, S., & Wu, D. (2020) · Current Drug Targets · doi:10.2174/1389450121666200429114926 · Cited by 43
Loss of NLRP6 expression increases the severity of acute kidney injury
Rivas, L. V., Cuarental, L., Núñez, G., Sanz, A. B., Ortíz, A., & Sánchez-Niño, M. D. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz169 · Cited by 45
Netterberg, I., Li, C., Molinero, L. L., Budha, N. R., Sukumaran, S., Stroh, M., Jonsson, E. N., & Friberg, L. E. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1198 · Cited by 41
Shimoura, N., Nagai, H., Fujiwara, S., Jimbo, H., Yoshimoto, T., & Nishigori, C. (2017) · Archives of Dermatological Research · doi:10.1007/s00403-017-1735-2 · Cited by 40
Littwitz-Salomon, E., Malyshkina, A., Schimmer, S., & Dittmer, U. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01947 · Cited by 39
Takahara, T., Shimizu, M., Nakagishi, Y., Kinjo, N., & Yachie, A. (2014) · Rheumatology International · doi:10.1007/s00296-014-3059-2 · Cited by 40
Research progress on pyroptosis and its effect on the central nervous system
Hao, W., & Feng, C. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106333 · Cited by 42
Interleukin-18 modulation in autism spectrum disorders
Businaro, R., Corsi, M., Azzara, G., Raimo, T. D., Laviola, G., Romano, E., Ricci, L., Maccarrone, M., Aronica, E., Fuso, A., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0466-6 · Cited by 41
NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer
Sonnessa, M., Cioffi, A., Brunetti, O., Silvestris, N., Zito, F. A., Saponaro, C., & Mangia, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01587 · Cited by 39
Interleukin-18 serum levels in sepsis: Correlation with disease severity and inflammatory markers
Mierzchała-Pasierb, M., Krzystek‐Korpacka, M., Leśnik, P., Adamik, B., Płaczkowska, S., Serek, P., Gamian, A., & Lipińska-Gediga, M. (2019) · Cytokine · doi:10.1016/j.cyto.2019.04.003 · Cited by 38
IL-18 binding protein (IL-18BP) as a novel radiation countermeasure after radiation exposure in mice
Li, X., Cui, W., Hull, L., Wang, L., Yu, T., & Xiao, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-75675-5 · Cited by 38
Metadata
- Authors
- Novick, D., Kim, S., Kaplanski, G., & Dinarello, C. A.
- Affiliations
- Weizmann Institute of Science (IL)
- Konkuk University (KR)
- Aix-Marseille Université (FR)
- University of Colorado Denver (US)
- Corresponding author
- Dinarello, Charles A.
- Venue
- Seminars in Immunology
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 25
- Issue
- 6
- Pages
- 439-448
- ISSN
- 1044-5323 (ISSN-L)
- OpenAlex
- W2005242977
- Cited by
- 280
- References
- 165
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 16 · 2023: 23 · 2022: 20 · 2021: 23 · 2020: 36 · 2019: 21 · 2018: 29 · 2017: 28 · 2016: 35 · 2015: 20 · 2014: 9
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Immunology (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Cancer Institute (CA 046934, P30CA046934)
- National Institute of Allergy and Infectious Diseases (AI‑15614)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR‑45584, R01AR045584)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-18, IL-18BP, Th1 response, interferon-gamma, IL-18 receptor alpha, IL-1 family cytokines, pro-inflammatory effects, autoimmune disease, macrophage activation syndrome, sepsis, acute kidney injury
- MeSH terms
- Animals, Autoimmune Diseases, Heart Diseases, Humans, Inflammation, Interferon-gamma, Killer Cells, Natural, Shock, Septic, Th1 Cells, Interleukin-12, Inflammation Mediators, Caspase 1, Interleukin-18, Intercellular Signaling Peptides and Proteins, Mice, Macrophage Activation Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review